Latest News — Page 95

Globally, WhatsApp Messenger has emerged as one of the world’s fastest-growing MIM applications. It has particularly high penetration rates in India, Indonesia, Malaysia, Brazil and South Africa. The sub-Saharan African region is characterized by mixed migration flows and multiple health challenges, due to the inequalities experienced in access to healthcare disproportionately affect many groups including migrants and mobile populations. Given the existing structural factors impeding access to healthcare, coupled with high rates of mobile telephone use across the sub-Saharan African […]

Over the last year, we’ve made great progress towards this goal. In June 2022, NICE published our real-world evidence framework. The EMA and the European Medicines Regulatory Network recently established the Data Analysis and Real World Interrogation Network (DARWIN EU®). Using the OMOP CDM, DARWIN EU® delivers real-world evidence from across Europe on diseases, populations and the use and performance of medicines. This enables EMA and other organisations in the European medicines regulatory network to use this data whenever needed […]

After seven years of estrangement, the two countries finally decided this week to repair ties and reopen embassies. The two countries, and the rest of the Middle Eastern area, might reap significant benefits from this arrangement. The Chinese government acted as a mediator between Iran and Saudi Arabia this week, and the two countries agreed to reopen embassies and resume diplomatic relations seven years after they were closed. With the restoration of diplomatic ties, there is hope that the two […]

Introduction In public health, efficient management of Essential Medicines and Health Supplies (EMHS) is crucial. In Uganda, EMHS redistribution is a vital process that ensures healthcare facilities are equipped to serve their communities effectively.  Execution of the EMHS redistribution guidelines was lacking in public health facilities in Uganda. Just one third (33%) of the health facilities conformed with the EMHS redistribution guidelines. Understanding EMHS Redistribution EMHS redistribution involves transferring unused, non-expired health commodities from overstocked facilities to those in dire […]

Introduction The repatriation of paediatric stem cell transplants to Ireland stands as a promise for families affected by rare inherited conditions. This initiative promises to alleviate the emotional and financial strain of seeking treatment abroad, while potentially reducing healthcare expenditures. Understanding Stem Cell Transplants Stem cell transplants, particularly allogeneic haematopoietic stem cell transplants (HSCT), are life-saving procedures for children with rare conditions such as metabolic errors and haemoglobinopathies. Currently, these services are sought in the UK, under the HSE’s Treatment […]

Introduction: A transformative innovation in paediatric cardiac care is making waves: the Autus Valve. This pioneering paediatric pulmonary valve replacement promises to significantly reduce the need for invasive surgeries in children with congenital heart conditions. The Autus Valve: A Leap Forward in Pediatric Cardiology The Autus Valve stands as a glimmer of hope for approximately 110,000 children in the U.S. suffering from congenital pulmonary valve disease. Traditional prosthetic valves, unsuitable for growing bodies, necessitate multiple surgeries throughout childhood. The Autus […]

Abu Dhabi wrapped up the activities of “DoH Innovation Week 2023”, which included the announcement of the winners of the Healthcare Research and Innovation Grant and a series of panel discussions that tapped into several areas of innovation, such as, supporting entrepreneurs, design thinking, Artificial Intelligence (AI), and the National Innovation Strategy. This comes as part of DoH’s efforts to cement Abu Dhabi’s position as a leading destination for innovation in healthcare and a hub life sciences.

Abu Dhabi (DoH), is hosting “DoH Innovation Week 2023”. The four-day event will exhibit six start-ups representing the Abu Dhabi healthcare ecosystem

Introduction: New cancer therapies, such as pembrolizumab, come with high costs, presenting a unique challenge for resource allocation decisions across nations and healthcare systems. Developed countries with national universal health insurance coverage have established different methods. Time to Reimbursement of Pembrolizumab and other oncology treatment are of utmost importance for high level of care. These methods orderly and transparently assess new technologies before adding them to their list of reimbursed services. This process, known as the “fourth hurdle”, is a […]

Introduction: There is an ongoing and unrelenting effort to find better treatments for breast cancer, which is a major health concern worldwide. One promising development in this respect is the use of gene expression profiling (GEP) tests. These tests, performed on tumour samples from early-stage breast cancer patients, can help determine the potential benefits of chemotherapy post-surgery. Gene Expression Profiling Tests in Breast Cancer: The Health Information and Quality Authority (HIQA) recently published a rapid health technology assessment (HTA) on […]

Are you faced with health policy changes or looming systemic transformation? Simulation methods used in health policy and systems research (HPSR) can influence health policy making. Here is a study that illustrates how HPSR shaped universal health coverage. Health systems simulation helps prepare for uncertainty in health care systems.

Understanding THIQA’s Policy on Assisted Reproductive Services THIQA’s policy outlines the eligibility criteria, benefits, and reimbursement packages for Assisted Reproductive Techniques (ART) in Abu Dhabi. It is not a clinical management guideline, but rather a framework to ensure eligible patients in need of ART treatments receive coverage based on evidence-based medical criteria. Determining Medical Necessity in Assisted Reproductive Treatments THIQA covers Assisted Reproductive treatments deemed medically necessary. This could be due to a couple trying for pregnancy for at least […]

Opportunity to undertake an MSc in Health Economics at the University of London. Apply for a Fellowship Programme by 30 April 2023. The Office of Health Economics (OHE) provides various forms of support to the upcoming generation of health economists in order to fulfil our philanthropic goals. They have established an MSc Fellowship Programme in collaboration with City, University of London, and a PhD Programme at LSE, London School of Economics and Political Science, for individuals interested in pursuing postgraduate […]

The annual BHF conference is taking place in Cape Town from 14 -17 May 2023. Networking, collaboration and learning about emerging healthcare issues, innovation and industry action, and discussions regarding what’s next.

Introduction: Achieving universal health care (UHC) is a World Health Organisation (WHO) strategic priority, with the goal of 1 billion more people benefitting from universal health coverage by 2025. This publication on health and care workforce planning provides a rationale for the related actions of the Working for Health progression model. The Need for Planning and Financing: Planning and financing are integral to the efficient and cost-effective development of health and care workforce policies. Their importance is particularly evident in […]

Treatment guidelines for adults with active non-radiographic axial spondyloarthritis recommend the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Tumor Necrosis Factor-alpha (TNF-alpha) inhibitors. If these first-line treatments don’t work or aren’t suitable, doctors may consider secukinumab or ixekizumab (IL-17 inhibitors). Clinical trials show that upadacitinib, an oral Janus Kinase (JAK) inhibitor, can reduce symptoms and improve the quality of life in Spondyloarthritis (SpA) patients. This effectiveness rivals that of biologics. Clinicians use the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) […]